New Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting

Nektar Therapeutics (Nasdaq: NKTR) today presented new data from the ongoing REZOLVE-AD Phase 2b study in a late-breaking ...

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

Deep, stable and durable reductions in kallikrein observed Among 32 patients who received a 50 mg dose of lonvo-z as of data ...
Le Lézard

Well of Life Center Introduces Groundbreaking Non-Invasive Treatments for Incontinence, Body Sculpting, and Wellness: EMSELLAtm and EMSCULPT NEO®

The Well of Life Center for Natural Health is proud to announce the addition of two innovative treatments from BTL Industries?EMSELLAtm and EMSCULPT NEO®?bringing patients safe, effective, and ...
Healio

Use of raw then roasted peanuts reverses allergy for two infants

Two toddlers who had peanut allergy during infancy are now able to safely consume peanuts following a new protocol, according ...